Thymic disorders and myasthenia gravis: Genetic aspects

Annals of Medicine

Volumn 31, Issue SUPPL. 2, 1999, Pages 46-51

  Zelano, Giovanni ^a   Settesoldi, Daniela ^a   Lino, Maddalena M ^a   Batocchi, Annapaola ^a   Evoli, Amelia ^a   Tonali, Pietro A ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Genetics; Major histocompatibility complex; Myasthenia gravis; Polymorphisms; Tumour necrosis factor

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; LYMPHOTOXIN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMUS;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; THYMOMA; THYMUS HYPERPLASIA; THYMUS NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032747275     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Engel AG. Myasthenia gravis and myasthenic syndromes. Ann Neurol 1984; 16: 519-34.
2. Schonbeck S, Chrestel S, Hohlfeld R. Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Int Rev Neurobiol 1990; 32: 175-200.
3. Levinson AI, Wheatley LM. The thymus and the pathogenesis of myasthenia gravis. Clin Immunol Immunopathol 1996; 78: 1-5.
4. Vincent A. Aetiological factors in development of myasthenia gravis. Adv Neuroimmunol 1994; 4: 355-71.
5. Campbell RD, Milner CM. MHC genes in autoimmunity. Curr Opin Immunol 1993; 5: 887-93.
6. Newsom-Davis J, Willcox N, Schluep M. Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Ann N Y Acad Sci 1987; 505: 12-26.
7. Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579-84.
8. Dawkins R, Christiansen FT, Garlepp PH, Cluskey J, Hollingsworth PN, Zilko PJ. Disease associations with complotypes, supratypes and haplotypes. Immunol Rev 1983; 70: 1-22.
9. Müller-Hermelink HK, Marx A, Geuder K, Kirchner T. The pathological basis of thymoma-associated myasthenia gravis. Ann N Y Acad Sci 1993; 681: 56-65.
10. Vieira LM, Caillat-Zucman S, Gajdos P, Cohen-Kaminsky S, Casteur A, Bach J. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J Neuroimmunol 1993; 47: 115-22.
11. Pirskanen R, Carlsson B, Lefvert AK, Matell G, Olerup O, Smith E. DR/DQ haplotype determines clinical forms of myasthenia gravis. J Autoimmun 1991; 4: XVII.
12. Schalke B, Kirkner T, Marx A, Schmitt I, Andreasietz A, Müller-Hermelink HK, et al. The thymic remnant in the pathogenesis of thymoma associated myasthenia gravis. J Autoimmun 1991; 4: XLII.
13. Vandevyver C, Raus P, Stinissen P, Phlippaerts L, Cassiman JJ, Raus J. Polymorphism of the tumor necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet 1994; 21: 377-82.
14. Degli Esposti MP, Andreas A, Christiansen F, Schalke B, Albert E, Dawkins RL. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 1992; 35: 355-64.
15. Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Back L, et al. A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33: 37-49.
16. Pociot F, Briant L, Jongeneet CV, Molvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-31.
17. Jacob CO, Fronek Z, Lewis GD. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990; 87: 1233-7.
18. Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospsov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci U S A 1991; 88: 9717-21.
19. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human TNF locus. Numerous TNF/LT alleles tagged by two closely linked microsatellites in the upstream region of lymphotoxin (TNF-beta) gene. J Immunol 1991; 147: 1053-9.
20. Schonbeck S, Padberg F, Hohlfeld R, Wekerle H. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficient mice: a new model of myasthenia gravis. J Clin Invest 1992; 90: 245-50.
21. Schonbeck S, Padberg F, Marx A, Hohlfeld R, Wekerle H. Transplantation of myasthenia gravis thymus to SCID mice. Ann N Y Acad Sci 1993; 681: 66-73.
22. Spuler S, Sarropulos A, Marx A, Hohlfed R, Wekerle H. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Am J Pathol 1996; 148: 1359-65.
23. Zelano G, Lino MM, Evoli A, Settesoldi D, Batocchi AP, Torrente I, et al. Tumour necrosis factor beta gene polymorphism in myasthenia gravis. Eur J Immunogenet 1998; 25: 403-8.
24. Hjelmstrom P, Peacock CS, Giscombe R, Pirskanen R, Lefvert AK, Blackwell JM, et al. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis. J Neuroimmunol 1998; 88: 137-43.
25. Gu D, Wogensten L, Calcutt NA, Xia G, Zhu S, Merelie JP, et al. Myasthenia gravis-like syndrome induced by expression of interferon-gamma in the neuromuscular junction. J Exp Med 1995; 88: 547-55.
26. Feldmann M, Brennan FM, Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 1998; 17: 217-28.